mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.7 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.7 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |